Monitor for the reopening of the AI trading platform expected late Q3/early Q4 2026, which is critical for revenue generation. The $5.0M cash raise provides a short runway; watch for further dilution or additional financing needs if platform launch is delayed.
Price Chart
Executive Summary
DNA X (SONM) reported Q2 2026 results with zero revenue from continuing operations as its AI trading platform remains closed to the public. The company raised $5.0M in preferred stock post-quarter-end and converted $3.1M in notes to equity, strengthening its balance sheet but highlighting ongoing cash burn and no revenue generation. Net loss from continuing operations was $1.238M, with EPS of -$0.92 per share, though the filing lacks analyst consensus for a meaningful surprise calculation.
Key Financial Metrics
Key Facts
- No revenue from continuing operations in Q2 2026; AI trading platform remains closed to the public.
- Raised $5.0M in cash through preferred stock issuance at $6.00/share in July/August 2026.
- Converted $3.1M convertible note to preferred stock, reducing debt overhang.
- Cash position was $0.9M at quarter-end, supplemented by $5.0M post-quarter.
- Net loss from continuing operations was $1.238M, with EPS of -$0.92 per share.
- General & administrative expenses reduced to $1.278M from $1.471M year-over-year, reflecting downsizing.
Financial Impact
Zero revenue from continuing operations; $5.0M cash infusion from preferred stock; net loss of $1.238M from continuing operations.
Risk Factors
- No revenue from continuing operations; platform launch may be delayed beyond guidance.
- High cash burn rate relative to cash on hand; may require additional dilutive financing.
- Dilution risk from convertible preferred stock (one-for-one conversion to common) pending stockholder approval.
- Nasdaq listing compliance risk given $5M market cap and negative equity.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3347981 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 31, 2026 8w ago | 8-K | $3.53 $4.57 | ▲ +29.50% | ▲ +29.19% | $2.96 (−16.03%) |
Aug 27, 2026 8w ago | 8-K | $3.27 $4.06 | ▲ +24.16% | ▲ +24.26% | $2.96 (−9.48%) |
Aug 19, 2026 9w ago | Press Release | $3.44 $2.96 | ▲ +13.95% | ▲ +13.95% | $2.96 (+13.95%) |
Jul 2, 2026 16w ago | 8-K | $3.75 $3.25 | ▲ +13.33% | ▲ +12.92% | $2.96 (+21.07%) |
Jun 12, 2026 19w ago | EFFECT | $4.74 $4.05 | ▲ +14.56% | ▲ +16.34% | $2.96 (+37.55%) |
Jun 4, 2026 20w ago | 8-K | $4.75 $4.21 | ▼ −11.37% | ▼ −13.23% | $2.96 (−37.68%) |
May 27, 2026 21w ago | 8-K | $4.24 $5.70 | ▼ −34.43% | ▼ −37.58% | $2.96 (+30.19%) |
Apr 30, 2026 25w ago | 8-K / 10-K/A | $4.89 $4.73 | ▲ +3.27% | ▲ +8.56% | $2.96 (+39.47%) |
Apr 14, 2026 28w ago | 8-K | $3.15 $5.10 | ▲ +61.90% | ▲ +55.86% | $2.96 (−6.03%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers